Emma M Dangerfield

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Oxide Nanoparticles

Candida Albicans

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Foster, Emma M Dangerfield, Mattie S M Timmer, Bridget L Stocker, Brendan L Wilkinson
Probing Isosteric Replacement for Immunoadjuvant Design: Bis-Aryl Triazole Trehalolipids are Mincle Agonists. ACS medicinal chemistry letters 15 (6) (2024)
Emma M Dangerfield, Shigenari Ishizuka, Kristel Kodar, Sho Yamasaki, Mattie S M Timmer, Bridget L Stocker
Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants. Journal of medicinal chemistry (2024)
Emma M Dangerfield, Shigenari Ishizuka, Kristel Kodar, Sho Yamasaki, Mattie S M Timmer, Bridget L Stocker
Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants. Journal of medicinal chemistry 67 (7) (2024)
Emma M Dangerfield, Shigenari Ishizuka, Kristel Kodar, Sho Yamasaki, Mattie S M Timmer, Bridget L Stocker
Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants. Journal of medicinal chemistry 67 (7) (2024)
Michael J Foster, Emma M Dangerfield, Mattie S M Timmer, Bridget L Stocker, Brendan L Wilkinson
Probing Isosteric Replacement for Immunoadjuvant Design: Bis-Aryl Triazole Trehalolipids are Mincle Agonists. ACS medicinal chemistry letters 15 (6) (2024)
Garth Cameron, Janice M H Cheng, Dale I Godfrey, Mattie S M Timmer, Bridget L Stocker, Emma M Dangerfield
The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3. RSC advances 12 (29) (2022)